Vincent Lo Re III
Vincent Lo Re III
Assistant Professor of Medicine & Epidemiology, University of Pennsylvania
Verified email at
Cited by
Cited by
The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis
BR Yehia, AJ Schranz, CA Umscheid, VL Re III
PloS one 9 (7), e101554, 2014
Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C Virus–monoinfected patients: a cohort study
VL Re III, MJ Kallan, JP Tate, AR Localio, JK Lim, MB Goetz, MB Klein, ...
Annals of internal medicine 160 (6), 369-379, 2014
A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression
R Gross, B Yip, VL Re III, E Wood, CS Alexander, PR Harrigan, ...
The Journal of infectious diseases 194 (8), 1108-1114, 2006
Eosinophilic meningitis
VL Re III, SJ Gluckman
The American journal of medicine 114 (3), 217-223, 2003
Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection
Clinical infectious diseases: an official publication of the Infectious …, 2018
HCV epidemiology in high-risk groups and the risk of reinfection
H Midgard, A Weir, N Palmateer, VL Re III, JA Pineda, J Macías, ...
Journal of hepatology 65 (1), S33-S45, 2016
The short‐term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct‐acting antivirals: An ERCHIVES study
DK Li, Y Ren, DS Fierer, S Rutledge, OS Shaikh, V Lo Re III, T Simon, ...
Hepatology 67 (6), 2244-2253, 2018
Disparities in absolute denial of modern hepatitis C therapy by type of insurance
VL Re III, C Gowda, PN Urick, JT Halladay, A Binkley, DM Carbonari, ...
Clinical gastroenterology and hepatology 14 (7), 1035-1043, 2016
Validity of diagnostic codes and liver‐related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study
VL Re III, JK Lim, MB Goetz, J Tate, H Bathulapalli, MB Klein, D Rimland, ...
Pharmacoepidemiology and drug safety 20 (7), 689-699, 2011
Validation of three coding algorithms to identify patients with end‐stage liver disease in an administrative database
D Goldberg, JD Lewis, SD Halpern, M Weiner, V Lo Re III
Pharmacoepidemiology and drug safety 21 (7), 765-769, 2012
The Yale cTAKES extensions for document classification: architecture and application
V Garla, VL Re III, Z Dorey-Stein, F Kidwai, M Scotch, J Womack, A Justice, ...
Journal of the American Medical Informatics Association 18 (5), 614-620, 2011
Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients
M DallaPiazza, VK Amorosa, R Localio, JR Kostman, VL Re
BMC infectious diseases 10 (1), 1-7, 2010
Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study
V Lo Re III, V Teal, AR Localio, VK Amorosa, DE Kaplan, R Gross
Annals of internal medicine 155 (6), 353-360, 2011
Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population‐based cohort study
KA Forde, K Haynes, AB Troxel, S Trooskin, MT Osterman, SE Kimmel, ...
Journal of viral hepatitis 19 (4), 271-277, 2012
Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection
V Lo Re III, J Volk, CW Newcomb, YX Yang, CP Freeman, S Hennessy, ...
Hepatology 56 (5), 1688-1698, 2012
Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study
GA McComsey, VL Re, M O'Riordan, UA Walker, D Lebrecht, E Baron, ...
Clinical infectious diseases 46 (8), 1290-1296, 2008
Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients
VL Re III, I Frank, R Gross, J Dockter, JM Linnen, C Giachetti, P Tebas, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 44 (3), 315-320, 2007
Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system
DS Goldberg, KA Forde, DM Carbonari, JD Lewis, KBF Leidl, KR Reddy, ...
Gastroenterology 148 (7), 1353-1361. e3, 2015
Liver fibrosis progression in hepatitis C virus infection after seroconversion
AA Butt, P Yan, VL Re, D Rimland, MB Goetz, D Leaf, MS Freiberg, ...
JAMA internal medicine 175 (2), 178-185, 2015
Adherence to hepatitis C virus therapy and early virologic outcomes
V Lo Re III, VK Amorosa, AR Localio, R O'Flynn, V Teal, ZD Stein, ...
Clinical Infectious Diseases 48 (2), 186-193, 2009
The system can't perform the operation now. Try again later.
Articles 1–20